Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
-
Published:2023-01
Issue:
Volume:179
Page:1-14
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Roth Gael S.ORCID,
Neuzillet Cindy,
Sarabi Matthieu,
Edeline JulienORCID,
Malka DavidORCID,
Lièvre Astrid
Subject
Cancer Research,Oncology
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies;Current Oncology;2024-06-21
2. Second-line FOLFOX chemotherapy for patients with advanced biliary tract cancers pretreated with cisplatin/gemcitabine: a systematic review and meta-analysis;ESMO Gastrointestinal Oncology;2024-06
3. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT);European Journal of Cancer;2024-05
4. Neoadjuvant immunotherapy based on PD-1/L1 Inhibitors for gastrointestinal tumor: a review of rationale and clinical advances;International Journal of Surgery;2024-03-21
5. Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25;Journal of Cellular and Molecular Medicine;2024-01-06